Black Diamond Therapeutics Inc (BDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 154,666 | 51,660 | N/A | N/A | N/A |
| Other current assets | 1,048 | 24 | 0 | 0 | 0 |
| TOTAL | $155,714 | $51,684 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 164 | 134 | N/A | N/A | N/A |
| Investments And Advances | 55 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 2,362 | 8 | 0 | 0 | 0 |
| TOTAL | $2,581 | $142 | $N/A | $N/A | $N/A |
| Total Assets | $158,295 | $51,826 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,964 | 416 | 0 | 0 | 0 |
| Accrued Expenses | 2,899 | 452 | N/A | N/A | N/A |
| Other current liabilities | N/A | 1,707 | N/A | N/A | N/A |
| TOTAL | $4,863 | $2,575 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 200,589 | 64,793 | 0 | 0 | 0 |
| TOTAL | $200,589 | $64,793 | $N/A | $N/A | $N/A |
| Total Liabilities | $205,452 | $67,368 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 1 | 1 | N/A | N/A | N/A |
| Retained earnings | -50,970 | -15,712 | N/A | N/A | N/A |
| TOTAL | $-47,157 | $-15,542 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $158,295 | $51,826 | $0 | $0 | $0 |